CompletedNot Applicable

The REMINDER Program for Older Adults Supported by Residential and Daycare Facilities

Portugal25 participantsStarted 2023-07-20

Plain-language summary

Dementia and mild cognitive impairment (MCI) deeply impact individuals' well-being and are expected to increase due to population aging, with global cases projected to rise to 152.8 million by 2050. Social isolation, accounting for 4% of dementia cases, emerges as a critical modifiable risk factor, particularly in institutionalized older adults, where it significantly raises dementia risk. To address these challenges, the REMINDER program was developed as a tailored, multidomain intervention to reduce dementia risk, emphasizing social and cognitive engagement and advancing its adaptation and evaluation in Residential and Daycare Facilities (RDF). To assess the feasibility of REMINDER in older adults supported by RDF (recruitment, adherence, retention, acceptability, accessibility, and usability) and explore potential changes in cognitive and psychosocial outcomes.

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals aged 65 years and older * RDF users * Those with elementary reading and writing skills. Exclusion Criteria: * Have a clinical diagnosis of dementia and/or MMSE scores below the cutoff for the presence of dementia (MMSE \< 22-27, depending on education level) * Have a psychiatric or neurological condition that impairs cognition in the long term * Have sensory and functional deficits that compromised their participation in the neuropsychological assessment and throughout the intervention sessions.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Feasibility outcomes (quantitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (quantitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (quantitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (qualitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (qualitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (qualitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Trial details

NCT IDNCT06733181

SponsorUniversity of Coimbra

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-31

View on ClinicalTrials.gov More Aging, Healthy trials

Plain-language summary

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Feasibility outcomes (quantitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (quantitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (quantitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (qualitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (qualitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention

Feasibility outcomes (qualitative)

Timeframe: During the intervention (at the end of the sessions) and 1-week after the intervention